Extramedullary B lymphoblastic leukemia/lymphoma (B-ALL/B-LBL): a diagnostic challenge

Clin Lymphoma Myeloma Leuk. 2014 Aug;14(4):e115-8. doi: 10.1016/j.clml.2014.01.004. Epub 2014 Feb 2.

Authors

Praveen Ramakrishnan Geethakumari¹, Marc S Hoffmann², Naveen Pemmaraju², Shimin Hu³, Jeffrey L Jorgensen³, Susan O'Brien², Naval Daver⁴

Affiliations

¹ Department of Internal Medicine, Albert Einstein Medical Center, Philadelphia, PA.
² Department of Leukemia, M.D. Anderson Cancer Center, University of Texas, Houston, TX.
³ Department of Hematopathology, M.D. Anderson Cancer Center, University of Texas, Houston, TX.
⁴ Department of Leukemia, M.D. Anderson Cancer Center, University of Texas, Houston, TX. Electronic address: NDaver@mdanderson.org.

No abstract available

Keywords: CXCR4/SDF-1 signaling; Extramedullary; Lymphoblastic lymphoma; Multi-agent chemotherapy; Multiplanar flow cytometry.

Publication types

Case Reports
Review

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Humans
Immunohistochemistry
Immunophenotyping
Male
Middle Aged
Positron-Emission Tomography
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / diagnosis*
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / drug therapy
Tomography, X-Ray Computed
Treatment Outcome

Grants and funding

P30 CA016672/CA/NCI NIH HHS/United States